Abcam (ABC) Sets New 1-Year High at $1,290.00
Abcam Plc (LON:ABC) shares reached a new 52-week high during trading on Wednesday . The stock traded as high as GBX 1,290 ($17.82) and last traded at GBX 1,280 ($17.68), with a volume of 224115 shares. The stock had previously closed at GBX 1,280 ($17.68).
Several research analysts have recently commented on the company. Peel Hunt reiterated a “hold” rating and issued a GBX 1,100 ($15.20) price objective on shares of Abcam in a report on Thursday, February 1st. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a GBX 946 ($13.07) price objective on shares of Abcam in a report on Monday, January 8th. Berenberg Bank reiterated a “buy” rating and issued a GBX 1,240 ($17.13) price objective on shares of Abcam in a report on Friday, January 5th. Finally, Numis Securities upgraded Abcam to a “buy” rating and set a GBX 1,200 ($16.58) price objective on the stock in a report on Friday, January 5th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company’s stock. Abcam presently has a consensus rating of “Hold” and an average price target of GBX 1,009.33 ($13.94).
The firm has a market cap of $2,600.00 and a price-to-earnings ratio of 6,095.24.
Abcam Company Profile
Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company’s purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways.
Receive News & Ratings for Abcam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam and related companies with MarketBeat.com's FREE daily email newsletter.